Menu
Log In Sign Up
Article

df3 peptide breast carcinoma

Published October Oct 17, 2026 5:57 PM

In the specialized arena of biochemical research, the terminology surrounding specific sequences can often lead to confusion. When exploring the DF3 peptide, it is essential to distinguish between the various entities that share this designation. From synthetic proteins to myostatin inhibitors, the scientific literature presents a complex landscape for those interested in molecular biology and protein engineering.

Defining the DF3 Peptide Entities

The term "DF3" appears in several distinct scientific contexts. It is crucial for researchers to verify the specific sequence and function required for their studies.

1. The DF3/MUC1 Antigen Complex

Historically, the most prominent association with DF3 is the monoclonal antibody (MAb) that reacts with a high molecular weight glycoprotein. This antigen is a member of a family of mucin-like glycoproteins that is aberrantly overexpressed in human breast carcinomas. Research often utilizes the breast carcinoma-associated antigen DF3 antibody to P3 peptide - Wikipedia study these specific markers. Furthermore, it has been established that DF3 recognizes the MUC-1 ta BPC-157 Benefits, Dosage & Before/After Results ndem repeat, a finding that has been pivotal in understanding the molec Fibronectin Binding Protein (FnBP Peptide D3) ular profile of mammary epithelium.

2. Synthetic Proteins and Metalloprotein Design

In the field of protein engineering, DF3 is the latest member of the DF fam by L Perey·1992·Cited by 124—TheDF3antigen is a member of a family of high molecular weight glycoproteins aberrantly expressed in malignant mammary epithelium.Read more ily of synthetic proteins. These are fascinating constructs, typically consisting of helix-loop-helix hairpi Interaction of the DF3/MUC1 Breast Carcinoma-associated ns des BPC-157 Benefits, Dosage & Before/After Results igned to dimerize and form an antiparallel four-helix bundle. These engineered molecules are fr Tumor Selective Reactivity of a Monoclonal Antibody equently studied for their specific spectroscopic and metal-binding properties, often demonstrating unique enzymatic activities, such as phenol oxidase activity, when the active site cleft is modified.

3. Myostatin Inhibitory Peptides

More recently, researchers have identified DF-3, a new myostatin inhibitory 14-mer peptide. This specific molecule functions by effectively inhibiting myostatin in *in vitro* assays. It is highly valued for its selectivity, as it typically fails to inhibit activin A or TGF-β1, making it a precise tool for studying muscle-related pathways at a molecular level.

4. Antimicrobial and Inhibitory Sequences

The broader category of peptides often includes defensins and inhibitory sequences. For instance, there is a global supplier of α-Defensin-3 (Human), which serves as a critical antimicrobial agent in immunological studies. Additionally, in the study of apoptosis, the dF3 peptide has been documented as a non-native sequence that can inhibit BAK activation in liposome assays, demonstrating the versatility of these short-chain amino acid structures.

Technical Considerations for Laboratory Use

When sourcing these materials, professionals must ensure the product exhibits correct molecular weight and purity. Whether you are looking for a blocking peptide—which binds specifically to the target antibody and blocks antibody binding—or a functional inhibitor, quality control is paramount.

For those looking into df-3 peptide buy options, it is standard practice to prioritize suppliers that provide detailed analytical data. Most research-grade peptides are supplied in a lyophilized form and require specific rehydration protocols to maintain their structural integrity. Always verify that the DF3 peptide you are sourcing matches the specific amino acid sequence required for your experimental design, as the nomenclature can be shared by entirely different functional molecules.

Summary by C Akewanlop·2001·Cited by 111—Monoclonal antibody (MAb)DF3 recognizes the MUC-1 tandem repeat. We investigated phagocytosis and cytolysis of cultured human breast cancer cells by monocyte- Read more of Research Applications

The versatility of these molecules is clear:

* Structural Biology: Investigating the four-helix bundle designs.

* Oncology Research: Utilizing monoclonal antibodies to detect specific antigens.

* Biochemistry: Testing the inhibitory capacity of novel 14-mer sequences against myostatin.

* Immunology: Applying defensins to study host defense mechanisms.

By maintaining a clear focus on the specific identity of the peptide in question, researchers can ensure their findings remain robust and reproducible. Whether your interest lies in the MUC-1 glycoprotein pathway or the latest developments in synthetic protein scaffolds, the study of these sequences continues to offer deep insights into molecular interactions.

Leave a Comment
Get new articles in your inbox

News, updates and freebies. No spam, unsubscribe anytime.